Immediate Impact
16 standout
Citing Papers
Invasion and metastasis in cancer: molecular insights and therapeutic targets
2025 Standout
Drug repurposing for cancer therapy
2024 Standout
Works of Oliver Tomé being referenced
A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO)
2016
Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Oliver Tomé | 49 | 32 | 15 | 68 | 42 | 13 | 124 | |
| Hans Ulrich Ulmer | 32 | 12 | 6 | 32 | 15 | 12 | 145 | |
| Ying Sun | 26 | 41 | 7 | 18 | 12 | 19 | 171 | |
| Stacy Wentworth | 78 | 79 | 64 | 54 | 10 | 198 | ||
| Mario Mileto | 24 | 14 | 2 | 49 | 29 | 11 | 103 | |
| Chad Winch | 31 | 59 | 12 | 23 | 9 | 15 | 156 | |
| Jennifer Goulart | 63 | 32 | 24 | 22 | 31 | 13 | 178 | |
| Kerstie Johnson | 62 | 25 | 12 | 41 | 13 | 12 | 159 | |
| Abdulla Alhasso | 54 | 122 | 2 | 35 | 14 | 15 | 193 | |
| Krystyna Reczko | 75 | 39 | 5 | 55 | 6 | 10 | 187 | |
| M. Benchalal | 90 | 63 | 1 | 27 | 17 | 19 | 168 |
All Works
Loading papers...